Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol. 2017 03; 66(3):545-551.
View in:
PubMed
subject areas
Ablation Techniques
Ablation Techniques
Adult
Adult
Aged
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Antineoplastic Agents
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Combined Modality Therapy
Combined Modality Therapy
CTLA-4 Antigen
CTLA-4 Antigen
Female
Female
Humans
Humans
Liver Neoplasms
Liver Neoplasms
Male
Male
Middle Aged
Middle Aged
Pilot Projects
Pilot Projects
authors with profiles
Susanna Ulahannan